BNTX (BioNTech SE) Short Interest


BNTX BioNTech SE BNTX
62 GF Score
Price $90.00
GF Value $89.20
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is BioNTech SE Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BNTX vs RPRX, INSM, ROIV: Short Interest Comparison

For the Biotechnology subindustry, BioNTech SE's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNTech SE Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioNTech SE's Short Interest distribution charts can be found below:

* The bar in red indicates where BioNTech SE's Short Interest falls into.


BNTX
62GF Score
BioNTech SE BNTX
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioNTech SE (BNTX) Overvalued in 2026?

Based on GuruFocus' analysis, BioNTech SE stock appears to be overvalued. The current stock price of $90.00 is trading 0.9% above its estimated GF Value™ of $89.20. GuruFocus considers BioNTech SE to be Fairly Valued.

Key valuation signals for BNTX:

  • Short Interest:
  • GF Value™: $89.20 vs. price of $90.00 (0.9% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the BNTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioNTech SE Business Description

Address An der Goldgrube 12, Mainz, RP, DEU, D-55131
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
62GF Score

Get the complete analysis for BNTX

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.00
Price
$89.20
GF Value